Hijjah 12, 1431H, Nov 18, 2010, SPA -- For more than a decade, millions of lives have been saved by statin drugs such as Lipitor and Zocor, which lower bad cholesterol and the risk of heart attacks. An experimental drug, called Anacetrapib, boosted good cholesterol so high and dropped bad cholesterol so low in a study that doctors were stunned and voiced renewed hopes for an entirely new way of preventing heart attack and stroke. "We are the most excited we have been in decades," said Dr. Christopher Cannon of Brigham and Women's Hospital in Boston, who led the study of the novel drug for Merck & Co. "This could really be the next big thing." --MORE
